Literature DB >> 3103628

Differential effects of manoalide on secreted and intracellular phospholipases.

C F Bennett, S Mong, M A Clarke, L I Kruse, S T Crooke.   

Abstract

Manoalide, a novel nonsteroidal sesterterpenoid, is a potent inhibitor of phospholipase A2 isolated from bee and cobra venoms. This report compares the inhibition by manoalide of phospholipase A2 in crude cytosol fractions from four mammalian tissues with that of four purified extracellular phospholipase A2's. Phospholipase A2 isolated from bee venom (Apis mellifera) was the most sensitive to inactivation by manoalide (IC50 approximately equal to 0.12 microM). Extracellular phospholipase A2 from rattlesnake and cobra venom was intermediate in sensitivity to manoalide (IC50 values of 0.7 and 1.9 microM respectively). Porcine pancreatic phospholipase A2 was relatively resistant to inactivation by manoalide (IC50 approximately equal to 30 microM). The phospholipase A2 assayed in crude cytosol fractions from four mammalian tissues exhibited IC50 values of 30 microM or greater. Cytosolic proteins as well as bovine serum albumin and poly-L-lysine (Mr = 57,000) protected purified bee venom phospholipase A2 from inactivation by manoalide. In contrast, amino acids such as lysine and alanine failed to protect the purified enzyme from inactivation. Proteins and certain amino acids, such as lysine, formed a chromogenic product when incubated with manoalide. These data suggest that lysine is capable of reacting with manoalide, but only when it is present in macromolecules is it capable of protecting phospholipase A2 from inactivation by manoalide. Because cellular proteins protect PLA2 from inactivation by manoalide, high concentrations of manoalide must be applied topically to produce statistically significant inactivation of intracellular phospholipase A2. Finally, a chemical model is presented which explains the formation of a chromogenic product when manoalide is incubated with proteins and amino acids.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3103628     DOI: 10.1016/0006-2952(87)90727-1

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  15 in total

1.  Phospholipase A2 inhibition by alkylbenzoylacrylic acids.

Authors:  T Köhler; G Friedrich; P Nuhn
Journal:  Agents Actions       Date:  1991-01

2.  Chemical modification and inactivation of phospholipases A2 by a manoalide analogue.

Authors:  S Fujii; Y Tahara; M Toyomoto; S Hada; H Nishimura; S Inoue; K Ikeda; Y Inagaki; S Katsumura; Y Samejima
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

Review 3.  Bioactive sesterterpenes and triterpenes from marine sponges: occurrence and pharmacological significance.

Authors:  Sherif S Ebada; Wenhan Lin; Peter Proksch
Journal:  Mar Drugs       Date:  2010-02-23       Impact factor: 5.118

4.  Differential inhibition of human secretory and cytosolic phospholipase A2.

Authors:  F Märki; W Breitenstein; E Beriger; R Bernasconi; G Caravatti; J E Francis; R Paioni; H U Wehrli; R Wiederkehr
Journal:  Agents Actions       Date:  1993-03

5.  AGN 190383, a novel phospholipase inhibitor with topical anti-inflammatory activity.

Authors:  G W De Vries; G Lee; L Amdahl; M Wenzel; M Garst; L A Wheeler
Journal:  Agents Actions       Date:  1991-09

6.  Manoalide, a phospholipase A2 inhibitor, inhibits arachidonate incorporation and turnover in brain phospholipids of the awake rat.

Authors:  E Grange; O Rabin; J Bell; M C Chang
Journal:  Neurochem Res       Date:  1998-10       Impact factor: 3.996

7.  The antiinflammatory activity of topically applied novel calcium-channel antagonists.

Authors:  G W De Vries; A McLaughlin; M B Wenzel; J Perez; D Harcourt; G Lee; M Garst; L A Wheeler
Journal:  Inflammation       Date:  1995-04       Impact factor: 4.092

8.  Sequence specific inhibition of human type II phospholipase A2 enzyme activity by phosphorothioate oligonucleotides.

Authors:  C F Bennett; M Y Chiang; L Wilson-Lingardo; J R Wyatt
Journal:  Nucleic Acids Res       Date:  1994-08-11       Impact factor: 16.971

9.  Effect of manoalide on human 5-lipoxygenase activity.

Authors:  F Cabré; A Carabaza; N Suesa; A M García; E Rotllan; M Gómez; D Tost; D Mauleón; G Carganico
Journal:  Inflamm Res       Date:  1996-05       Impact factor: 4.575

10.  Increased phospholipase A2 and lyso-phosphatidylcholine levels are associated with surfactant dysfunction in lung contusion injury in mice.

Authors:  David Machado-Aranda; Zhengdong Wang; Bi Yu; M V Suresh; Robert H Notter; Krishnan Raghavendran
Journal:  Surgery       Date:  2012-07-31       Impact factor: 3.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.